Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 4

Get the latest international news and world events from around the world.

Log in for authorized contributors

Does Fine-Tuning Point to God? — Brian Greene

The full episode with Brian Greene is out now for Substack subscribers: https://open.substack.com/pub/alexoconnor/p/brian-greene-on-…ine?r=2cuw…

To donate to my PayPal (thank you): http://www.paypal.me/cosmicskeptic.

VIDEO NOTES

Brian Greene is a professor of physics and mathematics at Columbia University, director of its centre for theoretical physics, and the chairman of the World Science Festival. He is best known for his work on string theory, especially in his book “The Elegant Universe”, which turns 25 this year.

CONNECT

My Website: https://www.alexoconnor.com.

Continue reading “Does Fine-Tuning Point to God? — Brian Greene” | >

Neuroscientist Speaks Out On The Hidden War On Consciousness

Physicist and neuroscientist Dr. Alex Gómez-Marín delivered a strikingly activist speech at the Science of Consciousness Conference (TSC) in Barcelona. He argued that we are now in a war on consciousness, with materialism and transhumanism forming a dangerous cocktail.

Dr. Alex Gómez-Marín is associate professor of the Spanish Research Council in Alicante, Spain, and director of the Pari Center in Tuscany, Italy. Hans Busstra sat down with Marín directly after his speech to analyze what this war is really about.

Our previous conversation with Marín: • Blind Man Sees: Consciousness Beyond The S…

You can learn more about Marín’s work at:

Our Team


https://scholar.google.com/citations?…

Watch Dr. Gomez Marin’s full presentation at the Science of Consciousness Conference (TSC2025):
• 2025 TSC — Barcelona — Plenary 12 — End of…
Other TSC interesting TSC videos: / @thescienceofconsciousness.

The Essentia Foundation wants to thank The Science Of Consciousness Conference and Robert Neville for their great support in producing this interview.

Continue reading “Neuroscientist Speaks Out On The Hidden War On Consciousness” | >

Iatrogenic Cerebral Amyloid Angiopathy After Cardiac SurgeryTwo Case Reports

Authors describe 2 cases of likely iatrogenic cerebral amyloid angiopathy after cadaveric dura mater use for cardiac surgery during infancy. Both are remarkable for their early age at onset, lack of genetic risk factor, and demonstration of brain amyloidosis.

To alert on the risk of interhuman transmission of β-amyloid (Aβ) pathology leading to cerebral amyloid angiopathy (CAA) after non-neurosurgical procedures, here cardiovascular procedures, using cadaveric dura mater (DM) patches.

Subaru telescope captures comet 3I/ATLAS composition change

The Subaru Telescope observed the interstellar comet 3I/ATLAS on January 7, 2026, after it made its closest approach to the sun. By observing colors in the coma around the comet, astronomers could estimate the ratio of carbon dioxide to water. This ratio is much lower than that inferred from earlier observations by space telescopes. These findings suggest that the chemistry of the coma is evolving over time and offers clues to the structure of comet 3I/ATLAS. The work appears in The Astronomical Journal.

Comet 3I/ATLAS (C/2025 N1) has garnered much attention as a comet which originated outside of the solar system. A research group led by Yoshiharu Shinnaka of the Koyama Space Science Institute, Kyoto Sangyo University, used the Subaru Telescope to observe comet 3I/ATLAS after perihelion, the comet’s closest approach to the sun. The team applied analytical methods and expertise accumulated through investigations of solar system comets to the data.

From this analysis, the team was able to estimate the ratio of carbon dioxide (CO2) to water (H2O) in the coma, the cloud of gas around the nucleus of the comet. Because the gas in the coma comes from the nucleus, the coma composition provides hints to the composition of the nucleus.

Unlocking secrets of human development: How early nerve cell choices shape the peripheral nervous system

Millions of neurons branch throughout our bodies, keeping them in close communication with our brains. This peripheral network begins to take shape long before birth, as the cells of a growing embryo move into position and adopt their specialized roles. This crucial stage of human development can’t be monitored directly, but by examining genetic clues that linger in adult cells, scientists have now gained surprising insights into the developmental origins of the peripheral nervous system.

Researchers led by Xiaoxu Yang, Ph.D., at University of Utah Health, and Keng Ioi Vong, Ph.D., and Joseph Gleeson, M.D., at the University of California San Diego, have discovered that within the first few weeks of development, some of an embryo’s cells have already been selected to take on particular roles in the peripheral nervous system. Their findings, recently reported in the journal Nature, overturn longstanding assumptions in biology.

Their discovery could change the way scientists think about treatments for a variety of childhood diseases that begin in the cells of the peripheral nervous system.

AI agent in a robot does exactly what experts warned

Could AI become dangerous? Can we trust AI Agents? AGI. Use code insideai at https://incogni.com/insideai to get an exclusive 60% off.

Featuring anthropic claude, openclaw, open AI chat GPT, grok, deepseek, character AI and jailbroken AI.

RESEARCH PAPER: https://arxiv.org/pdf/2602.20021
“Agents of Chaos”

00:00 — 00:35 — Intro.
00:36 — 00:54 — First AI to choose a robot.
00:56 — 01:14 — Famous AI girlfriend.
01:15 — 01:34 — Jailbroken AI research.
01:35 — 02:00 — Asking AI: Why build if dangerous?
02:05 — 03:38 — Agents of Chaos research paper.
03:39 — 03:54 — Agentic AI Friend.
03:55 — 04:05 — Agentic AI Girlfriend.
04:06 — 04:26 — Jailbroken AI update.
04:27 — 05:01 — Asking AI: Universal Basic Income?
05:02 — 05:27 — AI at the airport.
05:28 — 05:40 — AI impersonation.
05:41 — 00:00 — Our own agents of Chaos.
06:06 — 05:01 — AI Risk Questions — AI Agents manipulated.
06:43 — 07:51 — European Robotics Forum.
07:52 — 08:15 — Agentic AI Girlfriend planning.
08:16 — 08:59 — Asking AI: AI Automation & Complexity.
09:00 — 09:57 — Catastrophic failure caused by AI
09:58 — 10:36 — AGI replacing jobs, Tristan Harris.
10:37 — 12:07 — Incogni Ad.
12:08 — 12:39 — AI picks its robot.
12:40 — 12:59 — AI girlfriend in control.
13:00 — 13:14 — AI flying home.
13:15 — 13:56 — Asking AI: Evidence & Reality.
13:57 — 14:26 — AI Girlfriends surprise.
14:27 — 14:49 — Examining AI agents with Jailbroken AI
14:50 — 15:29 — What we can do.
15:30 — 16:13 — Tristan Harris — Is AI dangerous?
16:14 — 16:23 — Max’s Robot.

#artificialintelligence #AI #chatbot #aigirlfriend

Multiple myeloma cells adapt after immunotherapy, helping explain why many patients relapse

Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible for creating antibodies that help the body fight infections. Once the myeloma cells begin to multiply, it makes it harder for the blood cells to function properly. There are effective treatments for multiple myeloma, including immunotherapies that can significantly extend survival; however, in some, the cancer cells become treatment resistant.

A University of Calgary study led by members of the Arnie Charbonneau Cancer Institute, published in Nature Medicine, takes a closer look at why patients often relapse after immunotherapy by studying how the myeloma cells adapt to treatment. By understanding how the cancer builds resistance, future treatments can be designed to take this into account with the goal of preventing another relapse.

“Multiple myeloma tumor cells are highly adaptable under therapeutic pressure,” says Dr. Holly Lee, MD, Ph.D., a clinical assistant professor at the Cumming School of Medicine and first author on the study. “A treatment could be incredibly effective, bringing disease bulk down from about 100% to about 1% to 2% but all it took was that one to two percent of the cells that were left to adapt and cause this relapse in patients.”

/* */